Cellectar Biosciences Inc (NASDAQ:CLRB)

2.66
Delayed Data
As of Sep 29
 +0.12 / +4.72%
Today’s Change
1.25
Today|||52-Week Range
4.02
+55.56%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Cellectar Biosciences Inc have a median target of 10.50, with a high estimate of 20.00 and a low estimate of 7.00. The median estimate represents a +294.74% increase from the last price of 2.66.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Cellectar Biosciences Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.57
Sales
$0.00
Reporting Date
Nov 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 21.23%
 
 
 
 
 
 
Growthannually 40.19%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.